Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloperidone for Symptoms of Arousal in PTSD
NCT01917318Phase 2Terminated
- Sponsor
- University of Colorado Denver
- Start
- Jul 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iloperidone in post-traumatic stress disorder (PTSD), sponsored by University of Colorado Denver. Started Jul 2013; status: terminated.
02
Drugs
iloperidone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01917318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917318.